ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Novel Insights Into High Alloantibody Production in CCR5 KO Recipient Mice

J. L. Han1, J. M. Zimmerer2, Q. Zeng3, B. A. Ringwald1, C. K. Breuer3, G. L. Bumgardner2

1Ohio State University, Columbus, OH, 2Transplant Surgery, Ohio State University, Columbus, OH, 3Nationwide Children's Hospital, Columbus, OH

Meeting: 2020 American Transplant Congress

Abstract number: D-353

Keywords: Kidney transplantation, T cells

Session Information

Session Name: Poster Session D: Lymphocyte Biology: Signaling, Co-Stimulation, Regulation

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Antibody-mediated rejection (AMR) contributes to both early and late kidney allograft loss. Unfortunately, conventional immunosuppressants do not effectively control development of humoral alloimmunity in a substantial proportion of recipients, underscoring the importance of animal models that enable investigation of AMR immunobiology. CCR5 KO kidney transplant (KTx) recipients have proven to be a useful model to investigate immune mechanisms impacting AMR. CCR5 KO (H-2b) recipients of A/J (H-2a) KTx produce alloantibody titer that is 10-fold higher than in wild-type (WT) mice. A proposed mechanism for this heightened humoral response is impaired CD4+ T regulatory cell trafficking to the allograft and secondary lymphoid organs. We previously reported the discovery of a novel subset of CXCR5+IFN-γ+CD8+ T cells capable of killing alloprimed IgG+ B cells and mediating significant suppression of in vivo alloantibody production in an allogeneic hepatocellular Tx model. We hypothesized that high alloantibody producing CCR5 KO KTx recipients have reduced quantities of this novel regulatory CD8+ T cell subset.

*Methods: We investigated the quantity of CXCR5+IFN-γ+CD8+ T cells in peripheral blood and splenocytes of CCR5 KO compared to WT (C57BL/6, H-2b) hepatocyte and KTx recipients using flow cytometry.

*Results: CCR5 KO hepatocyte recipients had significantly fewer CXCR5+IFN-γ+CD8+ T cells in the spleen compared to WT recipients (8.75±2.73 x103 vs. 19.1±3.07 x103 cells; p=0.03). As expected, we found that CCR5 KO KTx recipients produce much higher quantity of alloantibody by day 14 postTx than WT recipients (5,800±700 vs. 1,200±100; p=0.0003) and have significantly reduced quantity of peripheral CXCR5+IFN-γ+CD8+ T cells (650±400 vs. 11,500±450 cells per million PBMCs; p=0.002). CXCR5 expression suggests that this peripheral CD8+ T cell subset traffics through lymphoid depots. RNA-seq analysis of mouse CXCR5+IFN-γ+CD8+ T cells show upregulated S1PR3 expression (140-fold vs. naïve CD8+ T cells), encoding a protein that facilitates temporary egress from lymphatics. Preliminary studies using GFP-fluorescent, alloprimed CXCR5+IFN-γ+CD8+ T cells injected into CCR5 KO KTx mice show that these cells are detected in the peripheral blood, spleen, and lymph nodes, but not the allograft. CCR5 KO KTx recipients that receive adoptive transfer of CXCR5+IFN-γ+CD8+ T cells (n=9) on day 5 postTx produce significantly less alloantibody than WT recipients (n=7) assayed on day 14 postTx (1,200±200 vs. 5,800±700; p<0.0001).

*Conclusions: Deficiency of these antibody-suppressor CD8+ T cells are likely an important immune mechanism driving the high alloantibody production in CCR5 KO KTx recipients. This subset exerts antibody suppressor function in lymphoid depots rather than in the kidney allograft itself.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Han JL, Zimmerer JM, Zeng Q, Ringwald BA, Breuer CK, Bumgardner GL. Novel Insights Into High Alloantibody Production in CCR5 KO Recipient Mice [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/novel-insights-into-high-alloantibody-production-in-ccr5-ko-recipient-mice/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences